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proline-rich domains to Cbl-b 1-481 (a.a. 1-595), were amplified by PCR, tagged with a Xpress or HA epitope and subcloned into the pEFneo plasmid. Point mutations, which replaced cysteine-372 with alanine (C372A), tryptophan-400 with alanine (W400A) in the RING finger of the full-length Cbl-b were made by site-directed mutagenesis (QuickChange, Stragagene, CA). The Myc-tagged Ub cDNA from an HA-tagged Ub plasmid (20) was generated by PCR and subcloned into pEFneo. The p85α plasmid with or without an HA tag, the p85α SH3 domain with an HA tag, and the HA-tagged p110α plasmid of PI3-K in pEFneo were provided by T. Mustelin. An SH3 domain deficient p85 (p85∆SH3) was constructed by subcloning the Bgl II and Xba I fragment of p85 into pEFneo with an HA tag. The lysis buffer (1% NP-40, 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 5 mM NaPiP, 2 mM Na 3 VO 4 , 10 µg/ml each of aprotinin and leupeptin). Cells were lysed for 10 min at 4 0 C and insoluble materials were removed by centrifugation at 15,000 x g (4 0 C for 10 min). For displaying ubiquitinated protein bands, 0.1% SDS was added into lysis buffer to disrupt non-specific protein-protein interaction.
Immunoprecipitation and Immunoblotting--For immunoprecipitation, lysates (~1x10 7 cells) were mixed with antibodies (1 µg) for 2 h, followed by addition of 30 µl of protein G-Sepharose beads (Santa Cruz Biotechnology) for an additional 2 h at 4 0 C. Immunoprecipitates were washed four times with 1 x Nonidet P-40 lysis buffer, and boiled in 20 µl 2x Laemmli's buffer. Samples were subjected to 8 or 10% SDS-PAGE analysis, and electrotransferred onto polyvinylidene difluoride membranes 6 (Millipore). Membranes were probed with the indicated primary antibodies (usually 1 µg/ml), followed by horseradish peroxidase-conjugeted secondary antibodies. Membranes were then washed and visualized with enhanced chemiluminescence detection system (ECL, Amersham Corp.). When necessary, membranes were stripped by incubation in stripping buffer (62.5 mM Tris-HCl, pH 5.7, 100 mM 2-mercaptoethanol, 2% SDS) for 1h at 70 0 C with constant agitation, washed, and then reprobed with other antibodies as indicated.
Results
Cbl-b induces p85 ubiquitination--Classical PI3-K is composed of a p85 regulatory subunit and a p110 catalytic subunit. The p85 subunit contains an N-terminal SH3 domain and two C-terminal SH2
domains to mediate protein-protein interactions, and an inter-domain between the two SH2 domains for the association with p110 subunit (21) . Previous studies have shown that Cbl-b associates with PI3-K (14, 18) . The recent identification that Cbl functions as a RING-type E3 ligase for receptor tyrosine kinases promoted us to investigate whether PI3-K could be a target protein for Cbl-b-induced ubiquitination. As the first step, we examined whether p85 is ubiquitinated in vivo by transient result from coimmunoprecipitated proteins other than p85, we added 0.1% SDS to the lysis buffer to reduce non-specific protein-protein interaction. An additional control was included by using normal rabbit serum for immunoprecipitation, and it did not precipitate slowly migrating species (data not shown). The data indicates that the p85 subunit of PI3-K is poly-ubiquitinated, and Cbl-b can act as an E3 ligase for p85.
Cbl-b RING finger but not the variant SH2 domain is essential for its ligase activity--Recent studies including our own showed that Cbl RING finger recruits a Ubc E2 and an intact RING finger is required for the E2 binding and its E3 ligase activity (7) (8) (9) . Specifically, mutation at the conserved cysteine-381 to alanine (Cbl C381A) disrupts its E2 binding and the ligase activity (8) . We then examined whether mutation at the conserved cysteine-372 to alanine in Cbl-b (Cbl-b C372A), which is equivalent to Cbl C381A mutation, will affect its ligase activity towards p85 ubiquitination.
Coexpression of Cbl-b C372A completely abolished its ability to promote p85 ubiquitination ( Cbl-b physically associates with p85--E3 ligases confer specificity to the Ub system by directly interacting with the substrate proteins and help transfer Ub to them (24) . An interaction between Cbl-b and PI3-K has been demonstrated in primary T cells and in Jurkat T cells (14, 18 ) and this interaction is not mediated by the two SH2 domains of p85 (18) . To further confirm this interaction, we cotransfected HA epitope-tagged Cbl-b with p85 in Jurkat T cells. HA-Cbl-b was coimmunoprecipitated with p85 ( Fig. 3A) , as well as with Grb2, as previously described (18) . We We further mapped the p85 binding region in Cbl-b C-terminal portion. There are more than ten proline-rich stretches spanning the Cbl-b C-terminal region (2). Two cDNA fragments, which encode proteins encompassing the entire proline-rich sequences from a.a. 443 to a.a. 982, or the distal prolinerich region from a.a. 595 to a.a. 982, were generated and tagged with an HA-epitope. The interaction of these two proline-rich domains with p85 was analyzed by coimmunoprecipitation. Both fragment proteins bound to p85 to a similar degree (Fig. 5C ), under both resting and pervanadate-stimulated conditions, suggesting that the proximal proline-rich sequences are less important for p85 interaction.
To further confirm that the distal proline-rich sequences are the primary binding region for p85, we compared the p85 interaction of the full-length Cbl-b with that of the 595-982 mutant. The 595-membrane showed equivalent amounts of proteins for the wild-type Cbl-b and the 595-982 mutant.
The data consists with the idea that the distal proline-rich region contains the primary binding sequences for p85.
A functional role for the C-terminal proline-rich region of Cbl-b was assessed in p85 ubiquitination. Removal of the distal proline-rich sequence in Cbl-b (Cbl-b 1-595), which reduced its interaction with p85 ( Fig. 5B) , severely lost its ability in promoting p85 ubiquitination (Fig. 6A) . The slight augmentation of p85 ubiquitination could be due to the residual binding of the 1-595 mutant to p85, as shown in Fig. 5B . Analysis of the cell lysates showed equivalent amounts of protein expression for the wild-type Cbl-b and the 1-595 mutant (Fig. 6B) . We conclude that the Cbl-b distal proline-rich sequences are required both for the efficient p85 binding and for its ubiquitination. We then investigated the possibility that Cbl-b regulates the upstream regulators for Vav activation. One of the well-established regulator is PI3-K, whose lipid product can bind to the PH domain of Vav and activates Vav nucleotide exchange activity (16, 17) . We demonstrated that Cbl-b induces Ub conjugation to p85, the regulatory subunit of PI3-K, which is dependent on its RING finger domain and distal proline-rich sequences, suggesting that Cbl-b acts as an E3 Ub ligase for p85. kinases, can also abrogates its Ub ligase activity towards these kinases (7, 23) . However, a corresponding mutation at Cbl-b (G298E) did not affect its activity to promote p85 ubiquitination, suggesting that the N-terminal variant SH2 domain of Cbl-b is dispensable for Ub conjugation to p85.
Rather, we showed that the C-terminal proline-rich region, and more specifically, the distal prolinerich sequences of Cbl-b is required for efficient p85 ubiquitination. Thus, our results suggest a novel mechanism by which Cbl-b C-terminal region can also recruit target proteins, and with the help of the RING finger, induces Ub transfer to them.
Our finding that the Cbl-b C-terminal region can recruit protein substrates is consistent with the recent crystal structural study on Cbl RING finger and an E2, UbcH7 (10) . In this complex, the active cysteine of the UbcH7, which forms an thiol-ester bond with Ub, is on the opposite side of the complex relative to the binding site for tyrosine kinase binding domain (N-terminal domain).
Therefore, a substrate that associates with the C-terminal region would presumably allow an easy transfer of Ub to the substrate. To further support our model, we recently found that the Cbl Cterminal region could also recruit protein substrates such as Stat5 and the RING finger and the Cterminal proline-rich region are sufficient for promoting Stat5 ubiquitination (27) . In fact, the Cbl The SH3 domain of p85 has been shown to mediate the interaction with the proline-rich sequence of another p85 molecule to form a p85 heterodimer (30) or the interaction with the proline-rich sequences of other molecules (31, 32) . We showed here that p85 SH3 domain can also interact with Cbl-b proline-rich sequences, which results in p85 ubiquitination promoted by Cbl-b E3 Ub ligase.
Thus, our study suggests a novel role for the SH3 domain of p85 in mediating its ubiquitination.
Poly-ubiquitination of protein substrates by the Ub system targets them for degradation by the 26S proteasome (11, 12) . However, modification of biological functions through ubiquitination of 
